High Court Decision Seen Enhancing India’s Drug Controls

Government legal experts in India say a recent Delhi High Court decision could have a major impact on the drug industry's ability to set prices and protect patents. Regulatory authorities read the court's decision to mean access to affordable drugs is a fundamental right of Indians. The National Pharmaceutical Pricing Authority says the decision supports its effort to impose universal price controls on all drugs considered essential. The decision also is seen in some quarters as authorizing the government to impose compulsory licensing arrangements so generics can be available. (Click here for more